Forte Biosciences (STU:37T) OCF Yield %: -6.69 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:37T Forte Biosciences Inc STU:37T
42 GF Score
Price €37.60
! 3 Warning Signs
View Full Analysis

What is Forte Biosciences OCF Yield %?

Forte Biosciences STU:37T -0.53% 42 OCF Yield % is -6.69 as of Jul. 15, 2026. GuruFocus rates STU:37T with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 1,410 Biotechnology companies, Forte Biosciences ranks better than 53.9% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Forte Biosciences's Trailing 12-Month Cash Flow from Operations is €-50.98 Mil, and Market Cap is €778.30 Mil. Therefore, Forte Biosciences's OCF Yield % for today is -6.69%.

The historical rank and industry rank for Forte Biosciences's OCF Yield % or its related term are showing as below:

STU:37T' s OCF Yield % Range Over the Past 10 Years
Min: -6.69   Med: 0   Max: -6.69
Current: -6.69


During the past 7 years, the highest OCF Yield % of Forte Biosciences was -6.69%. The lowest was -6.69%. And the median was %.

STU:37T's OCF Yield % is ranked better than
53.9% of 1410 companies
in the Biotechnology industry
Industry Median: -8.295 vs STU:37T: -6.69

Forte Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Forte Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Forte Biosciences OCF Yield % Related Terms


Forte Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Forte Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forte Biosciences OCF Yield % Chart

Forte Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -55.90 -39.48 -112.35 -61.24 -15.54

Forte Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -77.61 -37.88 -30.97 -20.11 -21.07

STU:37T vs AUTL, SGMT, BNTC: OCF Yield % Comparison

For the Biotechnology subindustry, Forte Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forte Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forte Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Forte Biosciences's OCF Yield % falls into.


STU:37T
42GF Score
Forte Biosciences Inc STU:37T
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forte Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Forte Biosciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-43.453 / 279.6768
=-15.54%

Forte Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-16.269 * 4 / 308.8242
=-21.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -6.69 mean?
Forte Biosciences (STU:37T) has a OCF Yield % of -6.69 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Forte Biosciences and its competitors. According to the industry distribution chart, Forte Biosciences ranks #650 out of 1410 companies in the Biotechnology industry, placing it in the top 46.1%.
Is Forte Biosciences' OCF Yield % too high?
Forte Biosciences' current OCF Yield % is -6.69. Based on the distribution chart, Forte Biosciences ranks #650 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Forte Biosciences has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Forte Biosciences' OCF Yield % compare to AUTL and SGMT?
According to the Biotechnology industry distribution chart, Forte Biosciences ranks #650 out of 1410 companies for OCF Yield %. This puts Forte Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Forte Biosciences and its competitors. Forte Biosciences's current OCF Yield % is -6.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forte Biosciences stock overvalued right now?
Forte Biosciences (STU:37T) has a current OCF Yield % of -6.69. The current OCF Yield % is -6.69. Forte Biosciences' overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Forte Biosciences (STU:37T), the current OCF Yield % is -6.69 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forte Biosciences Business Description

Other Exchanges FBRX:USA37T:Germany
Address 3060 Pegasus Park Drive, Building 6, Dallas, TX, USA, 75247
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
42GF Score

Get the complete analysis for STU:37T

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€37.60
Price